Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury

被引:63
作者
Nakamura, Yoshihiko [1 ]
Ishikura, Hiroyasu [1 ]
Nishida, Takeshi [1 ]
Kawano, Yasumasa [1 ]
Yuge, Rie [1 ]
Ichiki, Reiko [1 ]
Murai, Akira [1 ]
机构
[1] Fukuoka Univ, Fac Med, Dept Emergency & Crit Care Med, Jonan Ku, Fukuoka 8140180, Japan
来源
BMC ANESTHESIOLOGY | 2014年 / 14卷
关键词
Presepsin; Acute kidney injury; RIFLE criteria; Sepsis; Diagnosis; ACUTE-RENAL-FAILURE; INFLAMMATORY RESPONSE; QUALITY; THERAPY; SIRS; CARE;
D O I
10.1186/1471-2253-14-88
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Presepsin is useful for differentiating sepsis from non-infection related systemic inflammatory response syndrome. However, there are no studies investigating the usefulness of presepsin in diagnosing sepsis involving patients with acute kidney injury (AKI). The purpose of this study is to determine levels of blood presepsin in patients with or without sepsis and among non-AKI patients or patients with different degrees of AKI severity. Methods: This is a single center retrospective study. 247 patients admitted to the ICU between June 2010 and October 2012 were analyzed for their presepsin levels. We classified the patients into non-AKI and AKI according to the RIFLE (Risk, Injury, Failure, and Loss of kidney function and End-stage kidney disease or simply Loss and ESKD) criteria. We then sub-classified the patients in each group into either non-sepsis or sepsis sub-group and analyzed the accuracy of diagnosing sepsis based on their levels of presepsin. Results: The number of patients for each group was: non-AKI, 112; under AKI: Risk, 50; Injury, 36; Failure, 42; Loss and ESKD, 7. The levels of presepsin in sepsis groups were significantly higher than that in the non-sepsis group among the non-AKI, Risk and Injury patients (p < 0.0001, p < 0.01, p < 0.01, respectively). However, no significant difference in the level of presepsin between non-sepsis and sepsis groups among patients with Failure. In the receiver operating characteristic (ROC) analysis, the area under the curve (AUC) was 0.784 in the non-AKI group and 0.698 in the AKI comprising Risk, Injury and Failure groups. AUC value for non-AKI was not significantly different from that of AKI (p = 0.200). When 670 pg/mL was used as the cutoff value for presepsin, sensitivity and specificity were 70.3% and 81.3%, respectively. When 864 pg/mL was used as the cutoff value for presepsin, sensitivity and specificity were 71.4% and 63.8%, respectively. Conclusions: Presepsin level can be a reliable indicator of sepsis not only among non-AKI patients but also patients with less severe forms of AKI. However, it may not be a reliable indicator of sepsis in patients with a more advanced form of AKI.
引用
收藏
页数:7
相关论文
共 23 条
  • [21] Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
    Shirakawa, Kamon
    Naitou, Katsuki
    Hirose, Jirou
    Takahashi, Tomohiro
    Furusako, Shoji
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 937 - 939
  • [22] Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome
    Shozushima, Tatsuyori
    Takahashi, Gaku
    Matsumoto, Naoya
    Kojika, Masahiro
    Okamura, Yoshikazu
    Endo, Shigeatsu
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (06) : 764 - 769
  • [23] Yaegashi Yasunori, 2005, Journal of Infection and Chemotherapy, V11, P234, DOI 10.1007/s10156-005-0400-4